OMERS Administration Corp’s Alnylam Pharmaceuticals ALNY Stock Holding History

OMERS Administration Corp’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.36M	Hold	4,517	–	–	0.01%	639
2026 Q1	$1.49M	Hold	4,517	–	–	0.01%	571
2025 Q4	$1.8M	Hold	4,517	–	–	0.01%	419
2025 Q3	$2.06M	Hold	4,517	–	–	0.01%	403
2025 Q2	$1.47M	Hold	4,517	–	–	0.01%	451
2025 Q1	$1.22M	Sell	4,517 -735	-14%	-$189K	0.01%	518
2024 Q4	$1.24M	Buy	5,252 +891	+20%	+$234K	0.01%	472
2024 Q3	$1.2M	Hold	4,361	–	–	0.01%	485
2024 Q2	$1.06M	Buy	+4,361	New	+$688K	0.01%	521
2023 Q4	–	Sell	-4,000	Closed	-$708K	–	294
2023 Q3	$708K	Buy	+4,000	New	+$763K	0.01%	104

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OMERS Administration Corp's ALNY Position: Q2 2026 in Review

OMERS Administration Corp held its Alnylam Pharmaceuticals (ALNY) position steady in Q2 2026 at 4,517 shares worth $1.36M. The position accounts for 0.01% of the portfolio, ranked #639.

OMERS Administration Corp first reported a position in ALNY in Q3 2023 and has held it in 10 quarters since. The position peaked at $2.06M in Q3 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

OMERS Administration Corp held 4,517 shares of Alnylam Pharmaceuticals worth $1.36M as of Q2 2026.
OMERS Administration Corp left its Alnylam Pharmaceuticals share count unchanged in Q2 2026.
Alnylam Pharmaceuticals made up 0.01% of OMERS Administration Corp's portfolio in Q2 2026, its #639 holding.
OMERS Administration Corp first reported a position in Alnylam Pharmaceuticals in Q3 2023 and has held it in 10 quarters since.
OMERS Administration Corp's Alnylam Pharmaceuticals position peaked at $2.06M in Q3 2025.
790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.